View Item 

Show simple item record

Management of cyclic vomiting syndrome in adults: Evidence review
dc.contributor.authorSharaf, Ravi N.
dc.contributor.authorVenkatesan, Thangam
dc.contributor.authorShah, Raj
dc.contributor.authorLevinthal, David J.
dc.contributor.authorTarbell, Sally E.
dc.contributor.authorJaradeh, Safwan S.
dc.contributor.authorHasler, William L.
dc.contributor.authorIssenman, Robert M.
dc.contributor.authorAdams, Kathleen A.
dc.contributor.authorSarosiek, Irene
dc.contributor.authorStave, Christopher D.
dc.contributor.authorLi, B U. K.
dc.contributor.authorSultan, Shahnaz
dc.date.accessioned2019-07-03T19:56:17Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2019-07-03T19:56:17Z
dc.date.issued2019-06
dc.identifier.citationSharaf, Ravi N.; Venkatesan, Thangam; Shah, Raj; Levinthal, David J.; Tarbell, Sally E.; Jaradeh, Safwan S.; Hasler, William L.; Issenman, Robert M.; Adams, Kathleen A.; Sarosiek, Irene; Stave, Christopher D.; Li, B U. K.; Sultan, Shahnaz (2019). "Management of cyclic vomiting syndrome in adults: Evidence review." Neurogastroenterology & Motility : n/a-n/a.
dc.identifier.issn1350-1925
dc.identifier.issn1365-2982
dc.identifier.urihttps://hdl.handle.net/2027.42/149694
dc.description.abstractBackgroundThis evidence review was conducted to inform the accompanying clinical practice guideline on the management of cyclic vomiting syndrome (CVS) in adults.MethodsWe followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework and focused on interventions aimed at prophylactic management and abortive treatment of adults with CVS. Specifically, this evidence review addresses the following clinical questions: (a) Should the following pharmacologic agents be used for prophylaxis of CVS: amitriptyline, topiramate, aprepitant, zonisamide/levetiracetam, or mitochondrial supplements? (b) Should the following pharmacologic agents be used for abortive treatment: triptans or aprepitant?ResultsWe found very low‐quality evidence to support the use of the following agents for prophylactic and abortive treatment of CVS: amitriptyline, topiramate, aprepitant, zonisamide/levetiracetam, and mitochondrial supplements. We have moderate certainty of evidence for the use of triptans as abortive therapy. We found limited evidence to support the use of ondansetron and the treatment of co‐morbid conditions and complementary therapies.ConclusionsThis evidence review helps inform the accompanying guideline for the management of adults with CVS which is aimed at helping clinicians, patients, and policymakers, and should improve patient outcomes.
dc.publisherWiley Periodicals, Inc.
dc.subject.othertechnical review
dc.subject.othercyclic vomiting
dc.subject.othertreatment
dc.titleManagement of cyclic vomiting syndrome in adults: Evidence review
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149694/1/nmo13605.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149694/2/nmo13605_am.pdf
dc.identifier.doi10.1111/nmo.13605
dc.identifier.sourceNeurogastroenterology & Motility
dc.identifier.citedreferenceCristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014; 40: 309 ‐ 317.
dc.identifier.citedreferenceClouse RE, Sayuk GS, Lustman PJ, Prakash C. Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series. Clin Gastroenterol Hepatol. 2007; 5: 44 ‐ 48.
dc.identifier.citedreferenceJensen AD. Challenges With Acute Care and Response to Treatment Among Adult Patients With Cyclic Vomiting Syndrome. Gastroenterol Nurs. 2015; 38: 469 ‐ 476.
dc.identifier.citedreferenceLee LY, Abbott L, Mahlangu B, Moodie SJ, Anderson S. The management of cyclic vomiting syndrome: a systematic review. Eur J Gastroenterol Hepatol. 2012; 24: 1001 ‐ 1006.
dc.identifier.citedreferenceAbu‐Arafeh I, Russell G. Cyclical vomiting syndrome in children: a population‐based study. J Pediatr Gastroenterol Nutr. 1995; 21: 454 ‐ 458.
dc.identifier.citedreferenceSagar RC, Sood R, Gracie DJ, et al. Cyclic vomiting syndrome is a prevalent and under‐recognized condition in the gastroenterology outpatient clinic. Neurogastroenterol Motil. 2018; 30:.
dc.identifier.citedreferenceGuyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924 ‐ 926.
dc.identifier.citedreferenceAanpreung P, Vajaradul C. Cyclic vomiting syndrome in Thai children. J Med Assoc Thai. 2002; 85 ( Suppl 2 ): S743 ‐ S748.
dc.identifier.citedreferenceAndersen JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics. 1997; 100: 977 ‐ 981.
dc.identifier.citedreferenceBadihian N, Saneian H, Badihian S, Yaghini O. Prophylactic Therapy of Cyclic Vomiting Syndrome in Children: Comparison of Amitriptyline and Cyproheptadine: A Randomized Clinical Trial. Am J Gastroenterol. 2018; 113: 135 ‐ 140.
dc.identifier.citedreferenceBoles RG, Lovett‐Barr MR, Preston A, Li BU, Adams K. Treatment of cyclic vomiting syndrome with co‐enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol. 2010; 10: 10.
dc.identifier.citedreferenceBoles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co‐enzyme Q10, L‐carnitine and amitriptyline, a case series. BMC Neurol. 2011; 11: 102.
dc.identifier.citedreferenceHaghighat M, Rafie SM, Dehghani SM, Fallahi GH, Nejabat M. Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran. World J Gastroenterol. 2007; 13: 1833 ‐ 1836.
dc.identifier.citedreferenceHejazi RA, Reddymasu SC, Namin F, Lavenbarg T, Foran P, McCallum RW. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two‐year follow‐up study. J Clin Gastroenterol. 2010; 44: 18 ‐ 21.
dc.identifier.citedreferenceHikita T, Kodama H, Ogita K, Kaneko S, Nakamoto N, Mimaki M. Cyclic Vomiting Syndrome in Infants and Children: A Clinical Follow‐Up Study. Pediatr Neurol. 2016; 57: 29 ‐ 33.
dc.identifier.citedreferenceKumar N, Bashar Q, Reddy N, et al. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms–pediatric versus adult? BMC Gastroenterol. 2012; 12: 52.
dc.identifier.citedreferenceMoses J, Keilman A, Worley S, Radhakrishnan K, Rothner AD, Parikh S. Approach to the diagnosis and treatment of cyclic vomiting syndrome: a large single‐center experience with 106 patients. Pediatr Neurol. 2014; 50: 569 ‐ 573.
dc.identifier.citedreferenceNamin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil. 2007; 19: 196 ‐ 202.
dc.identifier.citedreferenceSezer OB, Sezer T. A New Approach to the Prophylaxis of Cyclic Vomiting: Topiramate. J Neurogastroenterol Motil. 2016; 22: 656 ‐ 660.
dc.identifier.citedreferenceHejazi RA, Lavenbarg TH, Foran P, McCallum RW. Who are the nonresponders to standard treatment with tricyclic antidepressant agents for cyclic vomiting syndrome in adults? Aliment Pharmacol Ther. 2010; 31: 295 ‐ 301.
dc.identifier.citedreferenceHikita T, Kodama H, Kaneko S, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia. 2011; 31: 504 ‐ 507.
dc.identifier.citedreferenceDerry CJ, Derry S, Moore RA. Sumatriptan (all routes of administration) for acute migraine attacks in adults ‐ overview of Cochrane reviews. Cochrane Database Syst Rev. 2014;: CD009108.
dc.identifier.citedreferenceLi BU, Murray RD, Heitlinger LA, Robbins JL, Hayes JR. Is cyclic vomiting syndrome related to migraine? J Pediatr. 1999; 134: 567 ‐ 572.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
nmo13605.pdf
Size:
1.715MB
Format:
PDF
View/Open
Name:
nmo13605_am.pdf
Size:
554.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.